HC-070 reduces time spent immobile in the FST in a dose and exposure-dependent fashion. by Stefan Just (4811358)

Atg14 plays a cell-intrinsic role in orchestrating eTreg survival but not terminal differentiation. by Erienne G. Norton (9612079)

“…PSEA of differentially accessible peaks in eTregs (|log₂FC | >  0.5, <i>P</i> <  0.05) derived from the spleen of <i>Foxp3</i>^Cre<i>Atg14</i>^fl/fl mixed BM chimera mice versus control counterparts, using public gene signatures [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003074#pbio.3003074.ref011" target="_blank">11</a>] of the indicated Treg populations (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003074#sec010" target="_blank">Materials and methods</a> for details) (<b>F</b>). …”

Knockdown of OIP5-AS1 leads to reduced cell apoptosis in I/R cell models. by Jingyan Yang (7120994)

Dynamics of deleterious mutation and selection at seven nuclear genes during barley domestication and de-domestication by Yu Zhou (22659476)

“…This study analyzed seven single-copy nuclear genes (Alcohol dehydrogenase 2 (ADH2), Alcohol dehydrogenase 3 (ADH3), Dehydrin9 (DHN9), Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Phosphoenolpyruvate carboxylase (PEPC), Photoperiod response gene (PPD-H1), and Granule-bound starch synthase (WAXY)) in 179 wild, 185 domesticated, and 21 de-domesticated barley accessions. …”

PRISMA flow chart for the selection of a systematic review and meta-analysis of ineffective breastfeeding techniques and their associated factors in Ethiopia. by Gizachew Yilak (8436942)

(a) Coastline length changes in the Caspian Sea; (b) LSI changes between 1985 and 2023 (P1 = 1985–1990, P2 = 1990–1995, P3 = 1995–2000, P4 = 2000–2005, P5 = 2005–2010, P6 = 2010–20... by Zihao Duan (17403792)

The <i>cop</i>^- and <i>cop</i>^<i>-</i> <i>apt</i>::<i>tetM</i> strains have similar aconitase (AcnA) activity after growth with Cu(II). by Javiera Norambuena (137228)

Lack of ComDE and/or AliB results in an attenuated inflammatory response to pneumococcal infection of the CSF. by Frank Schmidt (207186)

“…Eighteen hours later, CSF white blood cell (WBC) counts <b>(A)</b>, IL-1β <b>(B)</b>, and CXCL2 <b>(C)</b> levels were determined. <b>(A)</b> Mice infected with the single or double mutants showed significant decreases in CSF pleocytosis, as compared to D39 infected mice. …”

Did psychotherapy move to ZOOM and phone during COVID-19 in CZ, DE and SK? (INFOGRAPHICS) by Elke Humer (9261333)

Distribution of pulmonary ventilation assessed by the dorsal ventilation fraction in the anterior and posterior regions presented over the five time points: Induction-SB, MV-5min,... by Milena S. Nascimento (14803681)

Contrast modulates the cone frequency response—sum of sinusoids (SoS) stimuli. by Marcus H. C. Howlett (3921143)

Distribution of risk perception evaluation for the two subscales. by Martina Gnerre (12329356)

Discovery of <i>N</i>‑((3<i>S</i>,4<i>S</i>)‑4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl‑1<i>H</i>‑pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity by Jinxin Che (791250)

Discovery of <i>N</i>‑((3<i>S</i>,4<i>S</i>)‑4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl‑1<i>H</i>‑pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity by Jinxin Che (791250)

Discovery of <i>N</i>‑((3<i>S</i>,4<i>S</i>)‑4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl‑1<i>H</i>‑pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity by Jinxin Che (791250)

Discovery of <i>N</i>‑((3<i>S</i>,4<i>S</i>)‑4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl‑1<i>H</i>‑pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity by Jinxin Che (791250)

Discovery of <i>N</i>‑((3<i>S</i>,4<i>S</i>)‑4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl‑1<i>H</i>‑pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity by Jinxin Che (791250)

Discovery of <i>N</i>‑((3<i>S</i>,4<i>S</i>)‑4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl‑1<i>H</i>‑pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity by Jinxin Che (791250)

Discovery of <i>N</i>‑((3<i>S</i>,4<i>S</i>)‑4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl‑1<i>H</i>‑pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity by Jinxin Che (791250)

Image_5_PLAU Promotes Cell Proliferation and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.TIF by Guangjin Chen (1989892)

“…Notably, the downregulation of PLAU decreased the expression of TNFRSF12A. Moreover, knockdown TNFRSF12A also inhibits cell proliferation and migration. …”